QMUL spin-out Kinomica has been named as a finalist in the Bioseed “One to watch” category at the OBN (Oxford Biotechnology Network) awards 2020

Advanced proprietary bioinformatics and phosphoproteomics analytical methods developed at QMUL by lead inventor and Kinomica founder, Dr Pedro Cutillas, were patent- protected by Queen Mary Innovation and exclusively licensed to Kinomica. The company, a year after an Innovate UK award and seed investment has developed an impressive list of biopharma customers and is currently raising series A investment.